Dr. Mohamed Mohty
Full Professor of Hematology and Head of the Hematology and Cellular Therapy Department
Saint-Antoine Hospital and Sorbonne University
France
CME Accredited · Live Online Webinar
The Emerging Markets Multiple Myeloma Summit
From evidence to everyday practice: the evolving frontline treatment of multiple myeloma, with interactive cases and live expert debate.
Endorsed by
Webinar starts in
Friday, 23 October 2026 · 5:00 to 8:00 PM UAE (GMT +4) · 6:30 PM IST (GMT +5:30)
11
Expert Faculty
9
Countries
3 Hours
Live and Interactive
CME
Accredited
About the summit
Join leading experts from across the Emerging Markets as we explore the evolving frontline treatment of multiple myeloma, from evidence to everyday practice, with interactive cases and live expert debate.
The development, data and therapeutic integration of anti-CD38 antibodies, PIs and IMiDs in the frontline setting.
Real-world clinical cases that bring frontline decision making to life across Emerging Markets.
A moderated panel and open Q and A with faculty from nine countries.
Meet the experts
Full Professor of Hematology and Head of the Hematology and Cellular Therapy Department
Saint-Antoine Hospital and Sorbonne University
France
Consultant Hematologist
King Fahad Hospital, Medina Al Munawarah
Saudi Arabia
Clinical Hematologist at ABJ Oncology
Netcare Pretoria East Hospital
South Africa
Consultant Hematologist and BMT
Abu Dhabi Stem Cells Center
United Arab Emirates
Consultant in Internal Medicine, Hematology, and Hematological Oncology
Kuwait Cancer Control Center (KCCC)
Kuwait
Senior Consultant, Hematology and BMT
Sultan Qaboos University Hospital (SQUH)
Oman
Professor of Internal Medicine and Clinical Hematology
Cairo University
Egypt
Consultant in Adult Hematology and Bone Marrow Transplantation (BMT)
Princess Noorah Oncology Center
Saudi Arabia
Professor of Medicine (Hematology and Oncology) and Cell Biology
Founding Director of the BMT Program at AUBMC
American University of Beirut Medical Center
Lebanon
Founder and Director of Stem Cell Therapy Center (CTC)
Professor and Senior Consultant of Hematology and Oncology
University of Jordan
Jordan
Consultant in Adult Hematology and Internal Medicine
King Fahad Specialist Hospital
Saudi Arabia
Programme
Friday, 23 October 2026 · All times UAE (GMT +4), 4:00 PM KSA start · Hybrid, join live online
Welcome and Opening Remarks
Welcome, objectives of the virtual summit and housekeeping for the online format.
Asgar Rangoonwala, VP J&J IM Emerging Markets
Shaping the Next Frontier in Multiple Myeloma: J&JIM's Vision, Innovation Engine, and Future Pipeline
Maria Jazra, Head of Medical Affairs Emerging Markets
From Past Innovations to Future Horizons in Multiple Myeloma Care
Evolution of MM management, updates on disease parameters and treatment goals, and a glance into the future.
Dr. Mohamed Mohty (France)
Anti-CD38 mAbs in Multiple Myeloma: Development, Evidence and Therapeutic Integration
Key milestones, pivotal trials and integration into quadruplet regimens.
Dr. Ahmed Alhuraiji (Kuwait)
Moderator: Dr. Amal Elbeihani (KSA)
Practical Considerations in Frontline Multiple Myeloma: Anti-CD38 Antibodies, Proteasome Inhibitors and IMiDs
Administration modalities, prevention and management of adverse events, outpatient and home-based care.
Dr. Khalil Al Farsi (Oman)
Moderator: Dr. Romana Jassat (South Africa)
Interactive Clinical Case Discussion: The Real-World Face of Frontline Myeloma
Live polling and case-based discussion on evidence-based therapeutic strategy selection.
Dr. Mervat Mattar (Egypt)
Dr. Ihab El Hemaidi (KSA)
Moderator: Dr. Mohamed Abu Haleeqa (UAE)
Live Panel and Q&A: Optimizing the Frontline Treatments
Expert dialogue on optimal regimen selection and tailoring therapy to individual profiles, followed by audience Q&A.
Dr. Ali Bazarbachi (Lebanon)
Dr. Abdallah Abbadi (Jordan)
Dr. Omar Abduljalil (KSA)
Moderator: Dr. Mohamed Mohty (France)
Closing Remarks: Key Takeaways
Dr. Mohamed Mohty (France)
Registration is quick and free. Secure your place at the CURE-ious Beyond Borders live webinar and receive your joining link by email.
Endorsed by
Supported by
Powered by